An Open-Label, Long-Term extension Study to Evaluate the Safety and Tolerability of Simufilam 100mg Tablets in Participants With Mild to Moderate Alzheimer's Disease (2024-2025)
Experts
Dr
Rob Adam
Trials Medical Specialist
UQ Centre for Clinical Research
Faculty of Health, Medicine and Behavioural Sciences
